Mitochondrial VDAC1: function in cell life and death and a target for cancer therapy

V Shoshan-Barmatz1, M Golan

  • 1Department of Life Sciences, Ben-Gurion University of the Negev, Beer Sheva 84105, Israel. vardasb@bgu.ac.il

Current Medicinal Chemistry
|December 30, 2011
PubMed

Insights

Voltage-dependent anion channel (VDAC) regulates cell metabolism and apoptosis. VDAC1, bound to hexokinase, promotes cancer cell growth and chemoresistance, making it a therapeutic target.

Area of Science:

  • Mitochondrial biology
  • Cancer cell metabolism
  • Apoptosis regulation

Background:

  • The voltage-dependent anion channel (VDAC) is a crucial protein located on the outer mitochondrial membrane.
  • It acts as a gatekeeper, controlling the transport of ions and metabolites between mitochondria and the cytosol.
  • VDAC mediates the integration of mitochondrial functions with other cellular activities.

Purpose of the Study:

  • To review the roles of VDAC in regulating cell life and death, particularly in the context of cancer.
  • To discuss the significance of VDAC1-bound hexokinase (HK) in promoting the Warburg effect in cancer cells.
  • To highlight VDAC's involvement in mitochondria-mediated apoptosis and its potential as a therapeutic target.

Main Methods:

  • Literature review of current knowledge on VDAC function in cancer.
  • Analysis of VDAC's interaction with hexokinase and its impact on cellular metabolism.
  • Examination of VDAC's role in apoptosis pathways, including interactions with Bcl-2 family proteins.

Main Results:

  • VDAC is central to cellular metabolism and apoptosis.
  • VDAC1-bound hexokinase facilitates the high glycolytic phenotype in cancer cells, conferring a growth advantage.
  • Increased HK expression and VDAC binding enhance chemoresistance and apoptosis suppression.
  • VDAC is a target for Bcl-2 family proteins and mediates the release of apoptotic factors.

Conclusions:

  • VDAC plays a multifaceted role in cancer cell survival and proliferation.
  • The VDAC1-HK interaction is critical for tumor metabolic reprogramming and resistance to apoptosis.
  • VDAC1 represents a promising target for novel cancer therapeutics.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...